Inglis Tiffany Eul Davis
SEC insider (Form 3/4/5 filer). CIK 0002091798. Chief Medical Officer at SERA PROGNOSTICS, INC. (SERA). 5 reported Form 4/5 transactions since Sep 2024; latest on Oct 12, 2026. Located in SALT LAKE CITY, UT.
Companies Inglis Tiffany Eul Davis has filed insider reports for
- SERA PROGNOSTICS, INC. (SERA): Officer, Chief Medical Officer
Inglis Tiffany Eul Davis
CIK: 0002091798
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (60.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SERA
SERA PROGNOSTICS, INC.
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Oct 12, 2026SERA
SERA PROGNOSTICS, INC.
SaleDirect8K shares at avg. $2.03$16K - Sep 10, 2026SERA
SERA PROGNOSTICS, INC.
SaleDirect486 shares at avg. $2.00$972 - Jun 11, 2026SERA
SERA PROGNOSTICS, INC.
SaleDirect362 shares at avg. $2.01$727.62 - Mar 12, 2026SERA
SERA PROGNOSTICS, INC.
AwardDirect17.4K shares- - Oct 15, 2025SERA
SERA PROGNOSTICS, INC.
AwardDirect75K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 12, 2026 | SERA SERA PROGNOSTICS, INC. | Sale | 8,024 | $2.03 | $16,289 | Direct |
| Sep 10, 2026 | SERA SERA PROGNOSTICS, INC. | Sale | 486 | $2.00 | $972 | Direct |
| Jun 11, 2026 | SERA SERA PROGNOSTICS, INC. | Sale | 362 | $2.01 | $728 | Direct |
| Mar 12, 2026 | SERA SERA PROGNOSTICS, INC. | Award | 17,437 | - | $0 | Direct |
| Oct 15, 2025 | SERA SERA PROGNOSTICS, INC. | Award | 75,000 | - | - | Direct |
1-5 of 5 transactions